Originalsprog | Engelsk |
---|---|
Tidsskrift | Molecular Pharmaceutics |
Vol/bind | 17 |
Udgave nummer | 2 |
Sider (fra-til) | 426-440 |
ISSN | 1543-8384 |
DOI | |
Status | Udgivet - 2020 |
Adgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization. / Gentiluomo, Lorenzo; Svilenov, Hristo L.; Augustijn, Dillen; El Bialy, Inas; Greco, Maria Laura; Kulakova, Alina; Indrakumar, Sowmya; Mahapatra, Sujata; Morales, Marcello Martinez; Pohl, Christin; Roche, Aisling; Tosstorff, Andreas; Curtis, Robin; Derrick, Jeremy P.; Nørgaard, Allan; Khan, Tarik A.; Peters, Günther H. J.; Pluen, Alain; Rinnan, Åsmund; Streicher, Werner W.; van der Walle, Christopher F.; Uddin, Shahid; Winter, Gerhard; Roessner, Dierk; Harris, Pernille; Friess, Wolfgang.
I: Molecular Pharmaceutics, Bind 17, Nr. 2, 2020, s. 426-440.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization
AU - Gentiluomo, Lorenzo
AU - Svilenov, Hristo L.
AU - Augustijn, Dillen
AU - El Bialy, Inas
AU - Greco, Maria Laura
AU - Kulakova, Alina
AU - Indrakumar, Sowmya
AU - Mahapatra, Sujata
AU - Morales, Marcello Martinez
AU - Pohl, Christin
AU - Roche, Aisling
AU - Tosstorff, Andreas
AU - Curtis, Robin
AU - Derrick, Jeremy P.
AU - Nørgaard, Allan
AU - Khan, Tarik A.
AU - Peters, Günther H. J.
AU - Pluen, Alain
AU - Rinnan, Åsmund
AU - Streicher, Werner W.
AU - van der Walle, Christopher F.
AU - Uddin, Shahid
AU - Winter, Gerhard
AU - Roessner, Dierk
AU - Harris, Pernille
AU - Friess, Wolfgang
PY - 2020
Y1 - 2020
KW - therapeutic proteins
KW - protein formulation
KW - developability assessment
KW - protein characterization
U2 - 10.1021/acs.molpharmaceut.9b00852
DO - 10.1021/acs.molpharmaceut.9b00852
M3 - Journal article
C2 - 31790599
VL - 17
SP - 426
EP - 440
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
SN - 1543-8384
IS - 2
ER -